Old Logo.png
Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
10 sept. 2020 08h00 HE | Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
M2LOGO.jpg
M2 Compliance to Sponsor Rodman & Renshaw 21st Annual Global Investment Conference
06 sept. 2019 17h19 HE | M2 Compliance
Los Angeles, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a leading SEC registered filing agent, and financial printer will be proudly sponsoring the Rodman & Renshaw Conference,...
download-2.png
Emerald Health Therapeutics to Present at Rodman & Renshaw 21st Annual Global Investment Conference
28 août 2019 07h00 HE | Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that it will present a corporate overview and...
download-2.png
Emerald Health Therapeutics fera une présentation lors de la 21e conférence mondiale annuelle sur les investissements de Rodman & Renshaw
28 août 2019 07h00 HE | Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a annoncé aujourd'hui qu'elle présentera un aperçu...
M2LOGO.jpg
M2 to Sponsor the 20th Annual Global Investment Conference Hosted by Rodman & Renshaw (H.C. Wainwright & Co.)
03 sept. 2018 20h44 HE | M2 Compliance
New York, Sept. 03, 2018 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a global leading SEC registered filing agent and financial printer, announced it will be proudly sponsoring the 20th Annual Global...
yield10.png
Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018
28 août 2018 08h30 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28 août 2018 08h00 HE | VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
ADES Horizontal Centered Web.jpg
Advanced Emissions Solutions to Present at Rodman & Renshaw Global Investment Conference
05 sept. 2017 16h30 HE | Advanced Emissions Solutions, Inc.
HIGHLANDS RANCH, Colo., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the "Company" or "ADES") today announced that the Company will be presenting at the...
logo_343x193.png
Yield10 Bioscience to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
05 sept. 2017 08h30 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company focused on developing new technologies to achieve step-change improvements in crop yield to...
galectin.jpg
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
05 sept. 2017 08h30 HE | Galectin Therapeutics
NORCROSS, Ga., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will...